On March 18, 2025, Maravai LifeSciences announced its financial results for the year ended December 31, 2024, and restated its interim financial statements for Q2 and Q3 2024 due to a revenue recognition error of approximately $3.9 million.
AI Assistant
MARAVAI LIFESCIENCES HOLDINGS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.